Akt phosphorylates myc-associated zinc finger protein (MAZ), releases P-MAZ from the p53 promoter, and activates p53 transcription

Cancer Letters
Wei-Ping LeeShou-Dong Lee

Abstract

The p53 protein is a cell cycle regulator. When the cell cycle progresses, p53 plays an important role in putting a brake on the G1 phase to prevent unwanted errors during cell division. Akt is a downstream kinase of receptor tyrosine kinase. Upon activation, Akt phorphorylates IKK that then phosphorylates IκB and releases NF-κB, leading to transcriptional activation of Dmp1. Dmp1 is a transcriptional activator of Arf. It has been known that oncogene activation stabilizes p53 through transcriptional activation of Arf, which then binds and inhibits Mdm2. In the current study, we show that myc-associated zinc finger protein (MAZ) is a transcriptional repressor of the p53 promoter. Akt phosphorylates MAZ at Thr385, and the phosphorylated MAZ is released from the p53 promoter, leading to transcriptional activation of p53, a new mechanism that contributes to increased p53 protein pool during oncogene activation.

References

Dec 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·E SetoT Shenk
Aug 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·S A BossoneK B Marcu
Jul 5, 1991·Science·M HollsteinC C Harris
Mar 29, 1994·Proceedings of the National Academy of Sciences of the United States of America·C Y ChenM B Kastan
Oct 28, 1993·The New England Journal of Medicine·C C Harris, M Hollstein
Dec 1, 1995·Molecular and Cellular Biology·S D MillerC Prives
Feb 23, 1996·The Journal of Biological Chemistry·C L Parks, T Shenk
May 1, 1996·Genes & Development·L J Ko, C Prives
Jun 20, 1998·The Journal of Biological Chemistry·M V BlagosklonnyL Neckers
Aug 1, 1998·The Journal of Biological Chemistry·J SongK K Yokoyama
Oct 9, 1998·Genes & Development·A J Giaccia, M B Kastan
Nov 13, 1998·Science·M H CardoneJ C Reed
Jan 23, 1999·The Journal of Biological Chemistry·F Karantzoulis-FegarasP A Marsden
Mar 30, 2001·The Journal of Biological Chemistry·P CasaliniS Menard
Apr 20, 2001·Proceedings of the National Academy of Sciences of the United States of America·A W Lin, S W Lowe
Jun 8, 2001·The Journal of Biological Chemistry·J SongK K Yokoyama
Aug 16, 2001·Proceedings of the National Academy of Sciences of the United States of America·L D Mayo, D B Donner
Nov 21, 2001·Nature Cell Biology·B P ZhouM C Hung
Mar 30, 2002·The Journal of Biological Chemistry·Yoko OgawaraYukiko Gotoh
Dec 31, 2002·Toxicology·J A Pietenpol, Z A Stewart
Dec 10, 2003·Oncogene·Jordan S Fridman, Scott W Lowe
Feb 3, 2005·Nature Reviews. Molecular Cell Biology·Sagar Sengupta, Curtis C Harris
Sep 1, 2007·Cell Death and Differentiation·D X Liu, P E Lobie
Apr 17, 2012·Carcinogenesis·Lisa M Miller JenkinsEttore Appella
Dec 25, 2012·Nature Cell Biology·Patricia A J Muller, Karen H Vousden

❮ Previous
Next ❯

Citations

Sep 15, 2004·International Review of Cytology·Peter J Hurlin, Shala Dezfouli
Jun 24, 2020·Disease Models & Mechanisms·Olga Medina-MartinezMilan Jamrich
Nov 7, 2018·Cancer Investigation·Kazushi Inoue, Elizabeth A Fry
Feb 28, 2021·Nature Communications·Amir Ata SaeiRoman A Zubarev
Nov 18, 2020·Biochemistry. Biokhimii︠a︡·A A DaksN A Barlev
Aug 6, 2021·Blood Advances·Darya DeenDouglas Vernimmen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Signaling by Tyrosine Kinases

Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. RTKs have been shown not only to be key regulators of normal cellular processes but also to have a critical role in the development and progression of many types of cancer. Discover the latest research on cell signaling and RTK here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.